Oto laryngologists have not been as pro lific in promu lgating practice parameters and techn ology assessments as some of our colleagues in other specialties. We have m or e clin ical practice guidelines th an we do practice parameters, but even th ese were developed through a relatively informal process until recentl y. Since neith er pr actice param eters (or technology assessments) no r clinical pr actice guidelines have been a major focus for otolaryngologists, many of us are u nfamiliar wit h all of their po tential value, or th e pro blems that may be associated with th em .
Clinical practice guidelines sho uld be distinguished from practice parameters. Virtually all specialties have at least some clinical practice guide lines . They are essentially consensus statements on a specific topic and are intended "to assist practitioner and patient decisions about appropriate healthcare for specific clinical circumstances." Whi le the development process usually includes a review of literatur e and evidence, guidelines typically contain opinion (it may just be th e conse nsus of the guidelines committee that developed them) that may not be supported ent irely by irre futable evidence.
The Ame rican Academy of O tolarngology-Head and Neck Surge ry has issued such guidelines and policies. They are often developed by Academy committees and are published to document our best recommendations regardin g management of clinical conditions. The opinions developed by committees go th rough a rigorous review process and are vetted by the board before being ado pted by the Academy. They form a synthesis of the judgments of many of our best subspecialists and have been valuab le to our membership. So far, they have not resulted in significant legal action, but not all medical organizations have been that fortu nate . Connecticut attorney general alleged that IDSA had violated state antitrust law by advising against long-term antibiotics to treat "chronic Lyme disease (CLD) ." The IDSA, the Centers for Disease Control and Prevention, and the National Institutes of Health agree with that recom men datio n an d that "despite extensive study, no clear evidence has emerged to support th e con tention that CLD result s from a past or pers isten t Lyme disease infection ."
Despite th e scientific basis for th e IDSA guidelines, pro test by a CLD advocacy gro up led th e Connecticut attorney general to lau nch an investigation of IDSA' s guideline writ ing process. IDSA spent more than a quarter of a million dollars in legal expenses before settling with the attorney general and agreeing to a review panel to reassess the 2006 guidelines and processes." If the process for developing clinical guidelines is not rigorous, if there is any potential conflict of interest that could bias members of the committee, and if there is not transparency, clinical guidelines may open ind ividuals and organizations not on ly to civil suits, but also to anti trust litigation. Wh ile clin ical guidelines are important and serve a valuable functio n, it appears to be time for oto laryngologists to look more closely at our processes.
In contrast to clinical guideli nes, p ractice parameters and techno logy assessmen ts do not con tai n non -evidence-based consens us opinio n. Rather, they synt hesize all published evidence regard ing a specific topic and follow a rigorous development process . I have been involved with this process, and its purity is monitored carefully.t he American Academy of Neurology (AAN) is probably the most active organization in development of practice parameters, having published more than 100 practice parameters and technology assessmen ts since the mid 1990s. 5 Practice parameters and technology assessments ensure transparency by publishing all aspects of the process, including search terms, strategies, databases utilized, and any other relevant information. This allows readers to judge the validity of the pro cess. The practice-parame ter committees gather evidence-based studies on th e topi c in question, primarily clinical stu dies. Each article is classified (class I th rou gh class IV) on the basis of stre ngth of evidence (and risk of EDITORIAL bias), using criteria published previously in EAR, NOSE & THROA T ]OURNAL. 6 Memb ers of the pr actice-parameter and technology-assessment committees of the AAN (who will be authors of the published practice parameters) are selected to minimize bias and ensure balance within the committee. The AAN provides oversight, and the product of the committee is expected to synthes ize what is known about the topic, and to state the degree of certainty with which facts are known.
The practice parameters include recommendations determined strictly from evidence-based data . The recommendations may be (A) established as effective, ineffective, or harmful; (B) pro bab ly effective, ineffective, or harmful; (C) possib ly effective, ineffective, or harmful; or (U) data inadequate or conflicting; given current knowledge, treatment (test, predictor) is unproven .
Practice parameters and technology assessments have great value . They establish what is known or not known through evidence-based research. This process not only validates various treatments or tests , but it also highlights research that needs to be performed. In addition, it shines a bright light on the weaknesses in our literature. For example, in writing a practice parameter for laryngeal electromyography, we reviewed 584 articles . Only 33 qualified for inclusion on the basis of their stu dy designs . None of the articles was Class I or Class II. Only two were Class III, and the rest were Class IV (the lowest level of evide ncel.?" If slightly more thought had been given to study design, many of th e papers reviewed cou ld have been more credible.
Practice param eters and technology assessments also pose potential problems. For one, most physicians do not understand what they are, and they use them as clinical practice guidelines. They are not. They represent a synthesis of evidence -b ased data, not a consensus of expert opinion on clinical management. Furthermore, by design they are limited to addressing a specific, usually narrow, question; and it is often in-WHY PAY RETAIL?
Our surgical m icroscopes are meticulously reconditioned and g uaranteed for tw o years, at a fract ion o f t he cost o f new. In th is era of overw helming in for mation, pract ice parameters and technology assessme nts that synthesize evidence-bas ed dat a, an d clinic al practic e guidelin es th at combine evidence with a consen su s o f expert opinion, are both invalua ble reso ur ces to clin icians an d clinician resear che rs. The field of otolaryngology sho uld be at th e forefront of developing such docum ents. It m ay be appropriate for us to con sider increasing our activity in th ese areas; but it is inc um be nt for us to do so with th orough appreciation for th e complexiti es of the processes so th at we can prod uce th e best po ssible documents, with th e least possible risk of clinical mi suse or legal atta ck. 
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